Related Experiment Video
Updated: May 1, 2026
13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
11.4K
Development and implementation of papillomavirus prophylactic vaccines
1University of Queensland Diamantina Institute, Translational Research Institute, University of Queensland, Woolloongabba, Queensland 4102, Australia.
Journal of Immunology (Baltimore, Md. : 1950)
|April 22, 2014
Summary
Developing human papillomavirus (HPV) vaccines required 25 years of research, overcoming hurdles in technology, efficacy, and epidemiology. Ensuring global vaccine deployment remains crucial for preventing cervical cancer.
Area of Science:
- Oncology
- Virology
- Vaccinology
Background:
- Cervical cancer is a significant global health burden, causing over 250,000 deaths annually.
- The link between human papillomavirus (HPV) infection and cervical cancer spurred vaccine development efforts.
Purpose of the Study:
- To outline the scientific and logistical challenges in developing and deploying HPV vaccines.
- To highlight the translation of basic science discoveries into public health interventions for cancer prevention.
Main Methods:
- Development of viral antigen production technology.
- Demonstration of systemic immunization providing mucosal protection.
- Establishment of vaccine potency assays.
- Understanding HPV infection epidemiology and natural history.
Main Results:
- A 25-year scientific endeavor culminated in effective HPV vaccines.
- Key advancements included antigen technology, immune response validation, and epidemiological insights.
Conclusions:
- The development of HPV vaccines exemplifies successful global, academic-industrial collaborative research.
- Ensuring equitable deployment of these vaccines in high-need regions is the primary ongoing challenge for public health.
Related Concept Videos
01:30Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
01:51Vaccinations
44.1K
Overview
44.1K
01:21Vaccines
98
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
98
01:23Vaccine Production
144
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
144
01:22Development of Immunocompetence
1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
01:29Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K